Inari’s core products, FlowTriever and ClotTriever, are designed to treat blood clots without the need for thrombolytic drugs, differing from competitor offerings. This innovation provides a ...

Inari Medical has a fifty-two week low of $ ... The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein ...

Charles Schwab Investment Management Inc. grew its position in shares of Inari Medical, Inc. (NASDAQ:NARI – Free Report) by 2.6% during the 4th quarter, according to its most recent 13F filing with ...